{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0013158/OMIM:613154","label":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","mondoId":"MONDO:0013158","onsetQualifier":null,"recordKeys":["0371454628fdcb54d44dbe0880c150e896ea2f340a57ebca24b9e3bf42587663","07458d35858a576950a55122540349ed394fc9316342a5a89955928eec28d0bb","0795e3af7f4dc429f24f0475457a10498c64659b1ea2959457327b633e1f02d7","0cf8f8abb974d4a7b7bd5c5753eea1f8ed5008371a2a1442a076803711c538f6","11cd86973b407d6dc7fd5c21a97cc061502f841590bb5a8878a75cea3088a327","26eaf59d471993111c2d0a843d49f56bf9df5bd0036370c6145749d57e2225db","475ade2ad5c9cdda3a5bff08aebfe0b894fcafcb117c6d57ec2fd4ee3dc7db20","5404d38b2e68988d805d4c6f6dbb756ae74a4c64ee2d285fb7c0da35c8878e94","5c264cf2393331297c6dfa07a733487a18318bcb50423eeccf25c4d56771576c","65d4819774856d55d392dada2a4d4201203510b78a80a5f4399e86a11b4f0d83","7292b57d436b1ebb017cfb1611c2682cb58376d95f4bed90d4750bff5aa1b1c7","77836e482fdec63dccb433e814674f61459a59c2837bd90e475ca71278dd6eaf","7980bd4fd971771cfad0eef7fb28d9a6cb1c7fb3c2268c7f4983bfa3e870c060","a44a6d6069093a607a807a668c3dbca8d17c46c67f1aea1d2975b17ea4972dc0","a47a0dcc4de78b2930cac0d727d14c7b76edccd82b9428370588e906a73ea170","af88f093171dc00cb55978a1a57fa0aedb415b7437901942a922627a5b1b64b8","b83460fd9f1c5421163e89788fa1d87b94437872f92bfdd850d88c97b4b3c549","c1173a1be2c2783e08e4d217732a566e3e896b4a898cc5cad5c60091ae0bf4a3","c3e9f33b28a39333d15c49b28e15308960efd871b6226f989cf857092eb21f58","db6c324b9ef927cc9719839ab1bcabe4267231d399a6a32fe49e5ee9b2fcc617","deb33266fde62fcfd0e2971283db58da7ac862b44598d4a519cab8353a8e8b65","ea5f982567882cd94e45bf70e9e9abb6130ebaeebb76abe73de8cf9306f89fc5","eb5476756503c332e331b29928bdf51b79e9316a6ea6b3718eda75b70656c588","eff34e363d378c12e927b1832fa9591593fecc257130a51fa9a4c96d1098c5a3","f2438fe0af9f95d00f042874ff9a2af8e96f72d7a4bb843588bf6c3b7d4cf369","fd532d4f20fd49b041dd47aedc950929ce2bfa93d4e0c37583f9c71733e3e539"],"recordQualifiers":{},"scopeLabel":"OMIM:613154","sourceIds":["OMIM:613154"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0013158/OMIM:613154"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":19,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":26,"sourceGroups":{"omim":6,"orphanet":0,"published":20}},"features":[{"hpoId":"HP:0007063","label":"Aplasia of the inferior half of the cerebellar vermis","primary":false},{"hpoId":"HP:0001284","label":"Areflexia","primary":false},{"hpoId":"HP:0001321","label":"Cerebellar hypoplasia","primary":false},{"hpoId":"HP:0001305","label":"Dandy-Walker malformation","primary":false},{"hpoId":"HP:0000519","label":"Developmental cataract","primary":false},{"hpoId":"HP:0007082","label":"Dilated third ventricle","primary":false},{"hpoId":"HP:0031956","label":"Elevated circulating aspartate aminotransferase concentration","primary":false},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":false},{"hpoId":"HP:0001371","label":"Flexion contracture","primary":false},{"hpoId":"HP:0001290","label":"Generalized hypotonia","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0000238","label":"Hydrocephalus","primary":false},{"hpoId":"HP:0012110","label":"Hypoplasia of the pons","primary":false},{"hpoId":"HP:0025435","label":"Increased circulating lactate dehydrogenase concentration","primary":false},{"hpoId":"HP:0100297","label":"Increased endomysial connective tissue","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0006956","label":"Lateral ventricle dilatation","primary":false},{"hpoId":"HP:0003560","label":"Muscular dystrophy","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0008081","label":"Pes valgus","primary":false},{"hpoId":"HP:0000580","label":"Pigmentary retinopathy","primary":false},{"hpoId":"HP:0011484","label":"Posterior synechiae of the anterior chamber","primary":false},{"hpoId":"HP:0007973","label":"Retinal dysplasia","primary":false},{"hpoId":"HP:0006829","label":"Severe muscular hypotonia","primary":false},{"hpoId":"HP:0007260","label":"Type II lissencephaly","primary":false},{"hpoId":"HP:0002119","label":"Ventriculomegaly","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0013158","records":[{"frequencyKind":"count","key":"0371454628fdcb54d44dbe0880c150e896ea2f340a57ebca24b9e3bf42587663","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0031956","is_excluded":false,"label":"Elevated circulating aspartate aminotransferase concentration","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"07458d35858a576950a55122540349ed394fc9316342a5a89955928eec28d0bb","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000519","is_excluded":false,"label":"Developmental cataract","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"0795e3af7f4dc429f24f0475457a10498c64659b1ea2959457327b633e1f02d7","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000580","is_excluded":false,"label":"Pigmentary retinopathy","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"0cf8f8abb974d4a7b7bd5c5753eea1f8ed5008371a2a1442a076803711c538f6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"OMIM:613154","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"11cd86973b407d6dc7fd5c21a97cc061502f841590bb5a8878a75cea3088a327","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001321","is_excluded":false,"label":"Cerebellar hypoplasia","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"26eaf59d471993111c2d0a843d49f56bf9df5bd0036370c6145749d57e2225db","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"475ade2ad5c9cdda3a5bff08aebfe0b894fcafcb117c6d57ec2fd4ee3dc7db20","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0007260","is_excluded":false,"label":"Type II lissencephaly","onset_id":null,"reference":"OMIM:613154","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"5404d38b2e68988d805d4c6f6dbb756ae74a4c64ee2d285fb7c0da35c8878e94","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0011484","is_excluded":false,"label":"Posterior synechiae of the anterior chamber","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"5c264cf2393331297c6dfa07a733487a18318bcb50423eeccf25c4d56771576c","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"65d4819774856d55d392dada2a4d4201203510b78a80a5f4399e86a11b4f0d83","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0025435","is_excluded":false,"label":"Increased circulating lactate dehydrogenase concentration","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7292b57d436b1ebb017cfb1611c2682cb58376d95f4bed90d4750bff5aa1b1c7","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001290","is_excluded":false,"label":"Generalized hypotonia","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"77836e482fdec63dccb433e814674f61459a59c2837bd90e475ca71278dd6eaf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"7980bd4fd971771cfad0eef7fb28d9a6cb1c7fb3c2268c7f4983bfa3e870c060","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002119","is_excluded":false,"label":"Ventriculomegaly","onset_id":null,"reference":"OMIM:613154","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a44a6d6069093a607a807a668c3dbca8d17c46c67f1aea1d2975b17ea4972dc0","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0006829","is_excluded":false,"label":"Severe muscular hypotonia","onset_id":null,"reference":"OMIM:613154","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a47a0dcc4de78b2930cac0d727d14c7b76edccd82b9428370588e906a73ea170","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003560","is_excluded":false,"label":"Muscular dystrophy","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"af88f093171dc00cb55978a1a57fa0aedb415b7437901942a922627a5b1b64b8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0012110","is_excluded":false,"label":"Hypoplasia of the pons","onset_id":null,"reference":"OMIM:613154","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"b83460fd9f1c5421163e89788fa1d87b94437872f92bfdd850d88c97b4b3c549","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0007063","is_excluded":false,"label":"Aplasia of the inferior half of the cerebellar vermis","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c1173a1be2c2783e08e4d217732a566e3e896b4a898cc5cad5c60091ae0bf4a3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000238","is_excluded":false,"label":"Hydrocephalus","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c3e9f33b28a39333d15c49b28e15308960efd871b6226f989cf857092eb21f58","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0100297","is_excluded":false,"label":"Increased endomysial connective tissue","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"db6c324b9ef927cc9719839ab1bcabe4267231d399a6a32fe49e5ee9b2fcc617","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0007082","is_excluded":false,"label":"Dilated third ventricle","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"deb33266fde62fcfd0e2971283db58da7ac862b44598d4a519cab8353a8e8b65","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001284","is_excluded":false,"label":"Areflexia","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"ea5f982567882cd94e45bf70e9e9abb6130ebaeebb76abe73de8cf9306f89fc5","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001371","is_excluded":false,"label":"Flexion contracture","onset_id":null,"reference":"OMIM:613154","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"eb5476756503c332e331b29928bdf51b79e9316a6ea6b3718eda75b70656c588","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0006956","is_excluded":false,"label":"Lateral ventricle dilatation","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"eff34e363d378c12e927b1832fa9591593fecc257130a51fa9a4c96d1098c5a3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001305","is_excluded":false,"label":"Dandy-Walker malformation","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f2438fe0af9f95d00f042874ff9a2af8e96f72d7a4bb843588bf6c3b7d4cf369","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0007973","is_excluded":false,"label":"Retinal dysplasia","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"fd532d4f20fd49b041dd47aedc950929ce2bfa93d4e0c37583f9c71733e3e539","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0008081","is_excluded":false,"label":"Pes valgus","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"muscular-dystrophy-dystroglycanopathy-congenital-with-brain-and-eye-anomalies-type-a6","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6"},"schemaVersion":1}